株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

A群溶血性レンサ球菌咽頭炎診断 - 世界市場の見通し:2019年~2027年

GAS Pharyngitis Diagnostics - Global Market Outlook (2019 -2027)

発行 Stratistics Market Research Consulting 商品コード 942587
出版日 ページ情報 英文 173 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
A群溶血性レンサ球菌咽頭炎診断 - 世界市場の見通し:2019年~2027年 GAS Pharyngitis Diagnostics - Global Market Outlook (2019 -2027)
出版日: 2020年06月01日 ページ情報: 英文 173 Pages
概要

世界のA群溶血性レンサ球菌咽頭炎診断市場は、2019年の1億6988万米ドルから、2027年までに2億3250万米ドルに達し、予測期間中のCAGRで4.0%の成長が予測されています。A群溶血性レンサ球菌咽頭炎感染の発生率と有病率が、世界中で徐々に拡大しており、市場の成長を促進しています。ただし、正確かつ効率的で利用しやすい診断提供における問題点が、市場の成長を抑制しています。

当レポートでは、世界のA群溶血性レンサ球菌咽頭炎診断市場について調査分析し、市場概要、市場動向分析、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界のA群溶血性レンサ球菌咽頭炎診断市場:製品別

  • イントロダクション
  • PCRベース検査
  • 迅速検査キット
  • 培養検査

第6章 世界のA群溶血性レンサ球菌咽頭炎診断市場:エンドユーザー別

  • イントロダクション
  • 臨床検査室
  • 病院
  • 診療所

第7章 世界のA群溶血性レンサ球菌咽頭炎診断市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米
  • 中東・アフリカ

第8章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • M&A
  • 新製品の発売
  • 事業拡大
  • その他の主な戦略

第9章 企業プロファイル

  • Abbott Laboratories
  • BD
  • Beckman Coulter, Inc. (Danaher)
  • bioMerieux SA
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Sekisui Diagnostics
図表

List of Tables

  • Table 1 Global GAS Pharyngitis Diagnostics Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global GAS Pharyngitis Diagnostics Market Outlook, By Product (2018-2027) ($MN)
  • Table 3 Global GAS Pharyngitis Diagnostics Market Outlook, By PCR-based Test (2018-2027) ($MN)
  • Table 4 Global GAS Pharyngitis Diagnostics Market Outlook, By Rapid Test Kit (2018-2027) ($MN)
  • Table 5 Global GAS Pharyngitis Diagnostics Market Outlook, By Culture Test (2018-2027) ($MN)
  • Table 6 Global GAS Pharyngitis Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 7 Global GAS Pharyngitis Diagnostics Market Outlook, By Diagnostics Laboratories (2018-2027) ($MN)
  • Table 8 Global GAS Pharyngitis Diagnostics Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 9 Global GAS Pharyngitis Diagnostics Market Outlook, By Physician Clinics (2018-2027) ($MN)
  • Table 10 North America GAS Pharyngitis Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 11 North America GAS Pharyngitis Diagnostics Market Outlook, By Product (2018-2027) ($MN)
  • Table 12 North America GAS Pharyngitis Diagnostics Market Outlook, By PCR-based Test (2018-2027) ($MN)
  • Table 13 North America GAS Pharyngitis Diagnostics Market Outlook, By Rapid Test Kit (2018-2027) ($MN)
  • Table 14 North America GAS Pharyngitis Diagnostics Market Outlook, By Culture Test (2018-2027) ($MN)
  • Table 15 North America GAS Pharyngitis Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 16 North America GAS Pharyngitis Diagnostics Market Outlook, By Diagnostics Laboratories (2018-2027) ($MN)
  • Table 17 North America GAS Pharyngitis Diagnostics Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 18 North America GAS Pharyngitis Diagnostics Market Outlook, By Physician Clinics (2018-2027) ($MN)
  • Table 19 Europe GAS Pharyngitis Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 20 Europe GAS Pharyngitis Diagnostics Market Outlook, By Product (2018-2027) ($MN)
  • Table 21 Europe GAS Pharyngitis Diagnostics Market Outlook, By PCR-based Test (2018-2027) ($MN)
  • Table 22 Europe GAS Pharyngitis Diagnostics Market Outlook, By Rapid Test Kit (2018-2027) ($MN)
  • Table 23 Europe GAS Pharyngitis Diagnostics Market Outlook, By Culture Test (2018-2027) ($MN)
  • Table 24 Europe GAS Pharyngitis Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 25 Europe GAS Pharyngitis Diagnostics Market Outlook, By Diagnostics Laboratories (2018-2027) ($MN)
  • Table 26 Europe GAS Pharyngitis Diagnostics Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 27 Europe GAS Pharyngitis Diagnostics Market Outlook, By Physician Clinics (2018-2027) ($MN)
  • Table 28 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 29 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By Product (2018-2027) ($MN)
  • Table 30 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By PCR-based Test (2018-2027) ($MN)
  • Table 31 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By Rapid Test Kit (2018-2027) ($MN)
  • Table 32 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By Culture Test (2018-2027) ($MN)
  • Table 33 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 34 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By Diagnostics Laboratories (2018-2027) ($MN)
  • Table 35 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 36 Asia Pacific GAS Pharyngitis Diagnostics Market Outlook, By Physician Clinics (2018-2027) ($MN)
  • Table 37 South America GAS Pharyngitis Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 38 South America GAS Pharyngitis Diagnostics Market Outlook, By Product (2018-2027) ($MN)
  • Table 39 South America GAS Pharyngitis Diagnostics Market Outlook, By PCR-based Test (2018-2027) ($MN)
  • Table 40 South America GAS Pharyngitis Diagnostics Market Outlook, By Rapid Test Kit (2018-2027) ($MN)
  • Table 41 South America GAS Pharyngitis Diagnostics Market Outlook, By Culture Test (2018-2027) ($MN)
  • Table 42 South America GAS Pharyngitis Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 43 South America GAS Pharyngitis Diagnostics Market Outlook, By Diagnostics Laboratories (2018-2027) ($MN)
  • Table 44 South America GAS Pharyngitis Diagnostics Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 45 South America GAS Pharyngitis Diagnostics Market Outlook, By Physician Clinics (2018-2027) ($MN)
  • Table 46 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By Country (2018-2027) ($MN)
  • Table 47 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By Product (2018-2027) ($MN)
  • Table 48 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By PCR-based Test (2018-2027) ($MN)
  • Table 49 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By Rapid Test Kit (2018-2027) ($MN)
  • Table 50 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By Culture Test (2018-2027) ($MN)
  • Table 51 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By End User (2018-2027) ($MN)
  • Table 52 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By Diagnostics Laboratories (2018-2027) ($MN)
  • Table 53 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By Hospitals (2018-2027) ($MN)
  • Table 54 Middle East & Africa GAS Pharyngitis Diagnostics Market Outlook, By Physician Clinics (2018-2027) ($MN)
目次

According to Stratistics MRC, the Global GAS Pharyngitis Diagnostics Market is accounted for $169.88 million in 2019 and is expected to reach $232.50 million by 2027 growing at a CAGR of 4.0% during the forecast period. Incidence and prevalence of gas pharyngitis infections are gradually growing across the globe and thereby driving the growth of the market. However, issues in providing accurate, efficient, and accessible diagnostics are restraining the growth of the market.

Pharyngitis is inflammation of the pharynx, which is in the backside of the throat. It is most frequently referred to simply as sore throat. Numerous viral and bacterial agents can cause pharyngitis and GAS pharyngitis, is one of the bacterial infection caused by specially group a streptococcus. The market for GAS pharyngitis diagnostic is expected to increase significantly, as the occurrence of GAS pharyngitis rises, particularly among adolescents.

Based on the product, the rapid test kit segment is likely to have a huge demand due to the development for rapid point-of-care diagnosis mainly to be used in physician clinics and hospitals. Furthermore, ease of use and low cost per test are major factors expected to drive the segment.

By geography, North America is estimated to have a lucrative growth due to the favourable reimbursement facilities, high alertness among patients for GAS infection, rapid adoption of advanced tests, and presence of major players who constantly promote their brands through wide distribution channels are key factors pouring the market in the region.

Some of the key players profiled in the GAS Pharyngitis Diagnostics Market include Abbott Laboratories, BD, Beckman Coulter, Inc. (Danaher), bioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Meridian Bioscience, Inc., Quidel Corporation and Sekisui Diagnostics.

Products Covered:

  • PCR-based Test
  • Rapid Test Kit
  • Culture Test

End Users Covered:

  • Diagnostics Laboratories
  • Hospitals
  • Physician Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global GAS Pharyngitis Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 PCR-based Test
  • 5.3 Rapid Test Kit
  • 5.4 Culture Test

6 Global GAS Pharyngitis Diagnostics Market, By End User

  • 6.1 Introduction
  • 6.2 Diagnostics Laboratories
  • 6.3 Hospitals
  • 6.4 Physician Clinics

7 Global GAS Pharyngitis Diagnostics Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Abbott Laboratories
  • 9.2 BD
  • 9.3 Beckman Coulter, Inc. (Danaher)
  • 9.4 bioMerieux SA
  • 9.5 DiaSorin S.p.A.
  • 9.6 F. Hoffmann-La Roche Ltd
  • 9.7 Meridian Bioscience, Inc.
  • 9.8 Quidel Corporation
  • 9.9 Sekisui Diagnostics